Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR.
Oncotarget
Llerena, Susana S; García-Díaz, Nuria N; Curiel-Olmo, Soraya S; Agraz-Doblas, Antonio A; García-Blanco, Agustín A; Pisonero, Helena H; Varela, María M; Santibáñez, Miguel M; Almaraz, Carmen C; Cereceda, Laura L; Martínez, Nerea N; Arias-Loste, María Teresa MT; Puente, Ángela Á; Martín-Ramos, Luis L; de Lope, Carlos Rodríguez CR; Castillo-Suescun, Federico F; Cagigas-Fernandez, Carmen C; Isidro, Pablo P; Lopez-López, Carlos C; Lopez-Hoyos, Marcos M; Llorca, Javier J; Agüero, Jesús J; Crespo-Facorro, Benedicto B; Varela, Ignacio I; Piris, Miguel Ángel MÁ; Crespo, Javier J; Vaqué, José Pedro JP
Genetic and transcriptional evolution alters cancer cell line drug response.
Nature
Ben-David, Uri U; Siranosian, Benjamin B; Ha, Gavin G; Tang, Helen H; Oren, Yaara Y; Hinohara, Kunihiko K; Strathdee, Craig A CA; Dempster, Joshua J; Lyons, Nicholas J NJ; Burns, Robert R; Nag, Anwesha A; Kugener, Guillaume G; Cimini, Beth B; Tsvetkov, Peter P; Maruvka, Yosef E YE; O'Rourke, Ryan R; Garrity, Anthony A; Tubelli, Andrew A AA; Bandopadhayay, Pratiti P; Tsherniak, Aviad A; Vazquez, Francisca F; Wong, Bang B; Birger, Chet C; Ghandi, Mahmoud M; Thorner, Aaron R AR; Bittker, Joshua A JA; Meyerson, Matthew M; Getz, Gad G; Beroukhim, Rameen R; Golub, Todd R TR